Brazil's CSN agrees $2.3 billion deal set to sell cement unit to China's Huaxin

By Reuters News

- Brazil's CSN has signed an agreement to sell its cement unit, CSN Cimentos, to China's Huaxin in a deal valuing the business at 12.7 billion reais ($2.31 billion) on an enterprise-value basis, it said on Sunday.

In a securities filing, the steelmaker said the transaction agreed on Saturday was a step in its strategy to reduce debt and optimize its capital structure.

It is subject to customary closing conditions, CSN said, including approval from Brazil's antitrust regulator Cade, prior consent from power regulator Aneel and applicable Chinese regulatory approvals.

According to a translation of a separate filing by Huaxin, the Chinese company is expected to pay about 9.03 billion reais ($1.64 billion) for a 99.99% stake in CSN Cimentos, reflecting the target's agreed enterprise value after adjustments for debt and working capital.

Huaxin said CSN Cimentos accounts for about 21% of Brazil's cement market, adding that the acquisition would mark the first entry of a Chinese cement producer into the country. If completed, it would rank among the largest Chinese industrial acquisitions in Brazil's building materials sector, it added.

CSN, one of Brazil's largest steelmakers and iron ore miners, disclosed the valuation in late October, when it announced a 10-day exclusivity agreement with Huaxin to negotiate the sale.

It has been seeking to cut debt and increase earnings as it faces a weak steel market and pressure from low-cost imports, particularly from China.

The company made public a divestment plan in January that included the cement business.

Huaxin submitted the winning bid for CSN Cimentos in a competitive process launched in March 2026, according to previous company disclosures.

($1 = 5.5053 reais)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.
 

Cryptocurrency-related content is intended solely as news and market commentary. Crypto Derivatives are not available to Retail clients registered with Capital Com (UK) Ltd.